1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Radioactive Tracers Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Radioactive Tracers Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. Europe Radioactive Tracers Market Regional Analysis
6.1 Europe Radioactive Tracers Market Overview
6.2 Europe Radioactive Tracers Market Revenue 2020-2028 (US$ Million)
6.3 Europe Radioactive Tracers Market Forecast Analysis
7. Europe Radioactive Tracers Market Analysis – by Test Type
7.1 PET
- 7.1.1 Overview
- 7.1.2 PET: Europe Radioactive Tracers Market – Revenue and Forecast to 2031 (US$ Million)
7.2 SPECT
- 7.2.1 Overview
- 7.2.2 SPECT: Europe Radioactive Tracers Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Radioactive Tracers Market Analysis – by End User
8.1 Hospitals & Clinics
- 8.1.1 Overview
- 8.1.2 Hospitals & Clinics: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Diagnostic Centers
- 8.2.1 Overview
- 8.2.2 Diagnostic Centers: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
8.3 Academic & Research Institutes
- 8.3.1 Overview
- 8.3.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9. Europe Radioactive Tracers Market Analysis – by Tracer Type
9.1 Technetium-99m & Tc-97m
- 9.1.1 Overview
- 9.1.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Iodine-131
- 9.2.1 Overview
- 9.2.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Iron-59
- 9.3.1 Overview
- 9.3.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Lutetium-171
- 9.4.1 Overview
- 9.4.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Rubidium
- 9.5.1 Overview
- 9.5.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Chloride & Ammonia
- 9.6.1 Overview
- 9.6.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Scandium-46
- 9.7.1 Overview
- 9.7.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Seaborgium-269
- 9.8.1 Overview
- 9.8.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.9 Hassium-269
- 9.9.1 Overview
- 9.9.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.10 Gallium Citrate Ga 67
- 9.10.1 Overview
- 9.10.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.11 Prostate-Specific Membrane Antigen
- 9.11.1 Overview
- 9.11.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.12 FDDNP & FDOPA
- 9.12.1 Overview
- 9.12.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.13 Phosphorus-32 & Chromium-51
- 9.13.1 Overview
- 9.13.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.14 Thallium-201
- 9.14.1 Overview
- 9.14.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.15 F-18 FDG
- 9.15.1 Overview
- 9.15.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.16 F-18 FAPI
- 9.16.1 Overview
- 9.16.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.17 Ga-68 FAPI
- 9.17.1 Overview
- 9.17.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.18 F-18 PSMA
- 9.18.1 Overview
- 9.18.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
9.19 DOTATOC/DOTANOC/DOTATATE
- 9.19.1 Overview
- 9.19.2 Academic & Research Institutes: Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
10. Europe Radioactive Tracers Market – Europe Analysis
10.1 Europe
- 10.1.1 Europe Radioactive Tracers Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.1.1.1 Europe Radioactive Tracers Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 UK:
Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 UK: Europe Radioactive Tracers Market Breakdown, by Test Type
- 10.1.1.1.2 UK: Europe Radioactive Tracers Market Breakdown, by End User
- 10.1.1.1.3 UK: Europe Radioactive Tracers Market Breakdown, by Tracer Type
- 10.1.1.2 Germany:
Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Germany: Europe Radioactive Tracers Market Breakdown, by Test Type
- 10.1.1.2.2 Germany: Europe Radioactive Tracers Market Breakdown, by End User
- 10.1.1.2.3 Germany: Europe Radioactive Tracers Market Breakdown, by Tracer Type
- 10.1.1.3 France:
Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 France: Europe Radioactive Tracers Market Breakdown, by Test Type
- 10.1.1.3.2 France: Europe Radioactive Tracers Market Breakdown, by End User
- 10.1.1.3.3 France: Europe Radioactive Tracers Market Breakdown, by Tracer Type
- 10.1.1.4 Russia:
Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Russia: Europe Radioactive Tracers Market Breakdown, by Test Type
- 10.1.1.4.2 Russia: Europe Radioactive Tracers Market Breakdown, by End User
- 10.1.1.4.3 Russia: Europe Radioactive Tracers Market Breakdown, by Tracer Type
- 10.1.1.5 Italy:
Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.5.1 Italy: Europe Radioactive Tracers Market Breakdown, by Test Type
- 10.1.1.5.2 Italy: Europe Radioactive Tracers Market Breakdown, by End User
- 10.1.1.5.3 Italy: Europe Radioactive Tracers Market Breakdown, by Tracer Type
- 10.1.1.6 Rest of Europe:
Europe Radioactive Tracers Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.6.1 Rest of Europe: Europe Radioactive Tracers Market Breakdown, by Test Type
- 10.1.1.6.2 Rest of Europe: Europe Radioactive Tracers Market Breakdown, by End User
- 10.1.1.6.3 Rest of Europe: Europe Radioactive Tracers Market Breakdown, by Tracer Type
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Europe Radioactive Tracers Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Rotem Industries Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 ABX advanced biochemical compounds GmbH
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Invicro LLC
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Cardinal Health Inc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Newcastle University
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Novartis AG
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Curium
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Blue Earth Diagnostics Limited
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 General Electric Co
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 IBA Radiopharma Solutions
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights